Engineering humoral immunity as prophylaxis or therapy (Q26800101)

From Wikidata

Revision as of 15:48, 5 September 2016 by Harej (talk | contribs) (‎Added reference to claim: cites work (P2860): Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease (Q24635129), #quickstatements)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

No description defined

Language	Label	Description	Also known as
English	Engineering humoral immunity as prophylaxis or therapy	No description defined

Statements

instance of

scholarly article

0 references

title

Engineering humoral immunity as prophylaxis or therapy (English)

0 references

author name string

Cailin E Deal

series ordinal

1

0 references

Alejandro B Balazs

series ordinal

2

0 references

original language of film or TV show

English

0 references

publication date

August 2015

0 references

published in

Current Opinion in Immunology

0 references

volume

35

0 references

page(s)

113-22

0 references

cites work

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

1 reference

stated in

PubMed Central

Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease

1 reference

stated in

PubMed Central

Identifiers

DOI

10.1016/j.coi.2015.06.014

0 references

PMC publication ID

4553141

0 references

PubMed publication ID

26183209

0 references

 

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26800101&oldid=373709171"